KOMBOGLYZE
Swiss trademark · 613121 · Word mark · In force
Register entry
- Registration number
- 613121
- Application number
- 62588/2010
- Status
- In force
- Type
- Word mark
- Filed
- Nov 18, 2010
- Registered
- Mar 16, 2011
- Published
- Mar 16, 2011
- Protected until
- Nov 18, 2030
- Priority
- 29.09.2010 US
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmazeutische Präparate für die Behandlung von metabolischen Störungen.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 6, 2020
Agent’s address changed
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich → Keller Schneider Patent- und Markenanwälte AG (Zürich), Beethovenstrasse 49, Postfach, 8027 Zürich
Published in Swissreg on 06.10.2020
- May 22, 2020
Renewed
Published in Swissreg on 22.05.2020
- Apr 19, 2017
Agent’s address changed
- Representative
- Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49, Postfach, 8027 Zürich
Published in Swissreg on 19.04.2017
- May 6, 2014
Transferred
- Owner
- Bristol-Myers Squibb Company, 345 Park Avenue, New York, NY 10154, USA → AstraZeneca AB, Vastra Malarehamnen 9, 15185 Södertälje, Sweden
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich
Published in Swissreg on 06.05.2014
- Mar 16, 2011
Registered
Published in Swissreg on 16.03.2011
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.